Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

PX 866

  • Zoom
    PX 866
  • PX 866
Cat No: 13645
Biochemicals - Kinase Inhibitors
Cayman

PX 866 is a ring-opened analog of wortmannin (Item No. 10010591) that potently and irreversibly inhibits PI3K (IC50 = 0.1-88 nM).{24458,18123} It less potently blocks the activity of mammalian target of rapamycin (mTOR, IC50 = 3.1 µM).{18123} PX 866 e...

More

This product can only be bought through Cayman Chemical. Please contact us.

Territorial Availability: Available through Bertin Technologies only in France
Synonyms:
  • (1E,4S,4aR,5R,6aS,9aR)-5-(acetyloxy)-1-[(di-2-propen-1-ylamino)methylene]-4,4a,5,6,6a,8,9,9a-octahydro-11-hydroxy-4-(methoxymethyl)-4a,6a-dimethyl-cyclopenta[5,6]naphtho[1,2-c]pyran-2,7,10(1H)-trione
Correlated keywords:
  • inhibitors inhibits inhibitions cancers kinases proteins signal transductions intracellular signaling signals PXs 866 PX-866 PX866 ring-opened rings opened opens analogs wortmannin PI3K in vivo anti-tumors anti tumors antitumors cisplatin radiation treatments reduces reduction cells growth motility cytotoxicity PI3-Kinase PI3 10010591irreversible potent blocks mammalian targets rapamycin 13346 single agents activity effects three-dimensional 3D three dimensional cultures dosing patients increases diseases stable
Product Overview:
PX 866 is a ring-opened analog of wortmannin (Item No. 10010591) that potently and irreversibly inhibits PI3K (IC50 = 0.1-88 nM).{24458,18123} It less potently blocks the activity of mammalian target of rapamycin (mTOR, IC50 = 3.1 µM).{18123} PX 866 exhibits single agent in vivo anti-tumor activity and increases the anti-tumor effects of cisplatin and radiation treatment.{24458,24459} In cancer cells grown in three-dimensional cultures, PX 866 reduces cell growth and motility without causing cytotoxicity.{24457} Consistent with having cytostatic effects, PX 866 dosing is associated with prolonged stable disease in cancer patients.{24460}
Size 1 mg
Shipping dry ice
CAS Number 502632-66-8
Molecular Formula C29H35NO8
SMILES O=C(/C1=C\N(CC=C)CC=C)O[C@H](COC)[C@@]2(C)C1=C(O)C(C3=C2[C@H](OC(C)=O)C[C@@]4(C)[C@@]3([H])CCC4=O)=O
Molecular Weight 525,6
Formulation A crystalline solid
Purity ≥95%
Custom Code 2932.99
UNSPSC code 12352100

Click here to ask for your quote and get 15% off Cayman's products.

 

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : PX 866 There are 10 products.

Search